Alpha DNA Investment Management’s Vertiv VRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-17,999
Closed -$864K 252
2023
Q4
$864K Buy
+17,999
New +$766K 0.34% 56

Other funds holding VRT

Alpha DNA Investment Management's VRT Position: Q1 2024 in Review

Alpha DNA Investment Management sold out of Vertiv (VRT) in Q1 2024, closing a stake of 17,999 shares — an estimated $864K sold.

Alpha DNA Investment Management first reported a position in VRT in Q4 2023 and held it in 1 quarter. The position peaked at $864K in Q4 2023. 760 funds tracked by Wall St. Rank hold VRT as of Q1 2024.

  • Alpha DNA Investment Management reported no remaining Vertiv position as of Q1 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 17,999 Vertiv shares in Q1 2024, an estimated $864K.
  • Alpha DNA Investment Management first reported a position in Vertiv in Q4 2023 and held it in 1 quarter.
  • Alpha DNA Investment Management's Vertiv position peaked at $864K in Q4 2023.
  • 760 funds tracked by Wall St. Rank held Vertiv as of Q1 2024.

Based on Alpha DNA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.